BI-1358894
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for BI-1358894, covering 2023-05-11 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down Midazolam [Phase 1]